Evidence map›Paper›PMID 35529058›Full record

ArticleCardiology research and practice2022

Analysis of a Family with Brugada Syndrome and Sudden Cardiac Death Caused by a Novel Mutation of SCN5A.

Yao-Bin Zhu, Jian-Hui Zhang, Yuan-Yuan Ji, Ya-Nan Hu, Han-Lu Wang, Dan-Dan Ruan, Xiao-Rong Meng, Xin-Fu Lin, Jie-Wei Luo, Wei Chen

Open access · goldAbstract read
In one paragraph

Article in Cardiology research and practice, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Yao-Bin ZhuDepartment of Traditional Chinese Medicine, The First Affiliated Hospital, Fujian Medical University, Fuzhou 350001, China.ORCID https://orcid.org/0000-0003-2186-2286
Jian-Hui ZhangShengli Clinical Medical College of Fujian Medical University, Fuzhou 350001, China.ORCID https://orcid.org/0000-0002-3053-3428
Yuan-Yuan JiShengli Clinical Medical College of Fujian Medical University, Fuzhou 350001, China.ORCID https://orcid.org/0000-0001-8822-9894
Ya-Nan HuShengli Clinical Medical College of Fujian Medical University, Fuzhou 350001, China.ORCID https://orcid.org/0000-0001-6704-6108
Han-Lu WangShengli Clinical Medical College of Fujian Medical University, Fuzhou 350001, China.ORCID https://orcid.org/0000-0001-8867-4963
Dan-Dan RuanShengli Clinical Medical College of Fujian Medical University, Fuzhou 350001, China.ORCID https://orcid.org/0000-0001-9611-2979
Xiao-Rong MengShengli Clinical Medical College of Fujian Medical University, Fuzhou 350001, China.ORCID https://orcid.org/0000-0001-8668-4244
Xin-Fu LinShengli Clinical Medical College of Fujian Medical University, Fuzhou 350001, China.ORCID https://orcid.org/0000-0002-1065-1371
Jie-Wei LuoShengli Clinical Medical College of Fujian Medical University, Fuzhou 350001, China.ORCID https://orcid.org/0000-0003-4271-4848
Wei ChenShengli Clinical Medical College of Fujian Medical University, Fuzhou 350001, China.ORCID https://orcid.org/0000-0003-4224-9130
Fujian Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Brugada syndrome is a hereditary cardiac disease associated with mutations in ion channel genes. The clinical features include ventricular fibrillation, syncope, and sudden cardiac death. A family with Brugada syndrome with sudden cardiac death was analyzed to locate the associated mutation in the Methods and Results: Three generations of a Han Chinese family with Brugada syndrome were recruited in the study; their clinical phenotype data were collected and DNA samples extracted from the peripheral blood. Next-generation sequencing was carried out in the proband, and candidate genes and mutations were screened using the full exon capture technique. The family members who participated in the survey were tested for possible mutations using Sanger sequencing. Six family members were diagnosed with Brugada syndrome, including four asymptomatic patients. A newly discovered heterozygous mutation in the proband was located in exon 25 of SCN5A (NM_000335.5) at c.4313dup(p.Trp1439ValfsTer32). Among the surviving family members, only those with a Brugada wave on their electrocardiogram carried the c.4313dup(p.Trp1439ValfsTer32) variant. Bioinformatics prediction revealed that the frameshift of the c.4313dup (p.Trp1439ValfsTer32) mutant led to a coding change of 32 amino acids, followed by a stop codon, resulting in a truncated protein product. Conclusion: The newly discovered mutation site c.4313dup(p.Trp1439ValfsTer32) in exon 25 of SCN5A may be the molecular genetic basis of the family with Brugada syndrome.

Identifiers

PMID35529058
PMCPMC9072018
OpenAlexW4225161369

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.